FoU-Centrum Skaraborg - R&D Centre Skaraborg, Skövde, Sweden.
The Skaraborg Institute, Skövde, Sweden.
Int J Qual Stud Health Well-being. 2024 Dec;19(1):2389575. doi: 10.1080/17482631.2024.2389575. Epub 2024 Aug 11.
Guidelines recommend starting glucose-lowering drug upon type 2 diabetes mellitus diagnosis together with lifestyle changes. Lifestyle changes are as essential as the drug, earlier recommendations allowed some months of lifestyle changes while being drug-free. Prescription on diagnosis may interfere with patients' understanding and motivation for lifestyle changes if they cannot evaluate the effect on blood glucose.
A phenomenographic approach and interviews were conducted with patients who started a glucose-lowering drug at diagnosis.
Three qualitatively different conceptions of being prescribed glucose-lowering drugs in connection to type 2 diabetes mellitus diagnosis were found: "Drugs as something unwelcome," "Drugs as a support," and "Drugs as a means to reach the goal". These conceptions range broadly from drugs as unwelcome to drugs as a support for lifestyle changes and an opportunity to influence the course of the lifelong disease to reach a goal.
This study has identified various perspectives of patients' understanding of the role of lifestyle changes in managing their disease. The patients undergo a process, and the perspectives vary, providing a more extensive and nuanced understanding. It is, therefore, impossible to apply a routine protocol and a person-centred approach is required when prescribing a glucose-lowering drug.
指南建议在诊断 2 型糖尿病的同时,与生活方式改变一起开始使用降糖药物。生活方式改变与药物一样重要,早期的建议允许在不使用药物的情况下进行几个月的生活方式改变。如果患者无法评估血糖变化对药物的影响,那么在诊断时开处方可能会干扰他们对生活方式改变的理解和动力。
采用现象学方法和访谈对在诊断时开始使用降糖药物的患者进行研究。
发现了三种与 2 型糖尿病诊断相关的不同的接受降糖药物治疗的概念:“药物是不受欢迎的东西”、“药物是一种支持”和“药物是达到目标的手段”。这些概念从药物不受欢迎到药物作为生活方式改变的支持,以及影响终身疾病进程以达到目标的机会,范围广泛。
本研究确定了患者对生活方式改变在管理疾病中作用的不同理解角度。患者经历了一个过程,视角也随之变化,提供了更广泛和细致的理解。因此,不可能应用常规方案,需要在开处方时采用以患者为中心的方法。